HUMAN CELL DESIGN
A scientific approach can reshape what’s possible
Human Cell Design expertise support for more than a decade drug discovery industry & academia for identifying the most relevant biologics & compounds which could translate a scientific innovative approach into a large clinical success. Our team combines unique human disease models panel with high expertise in human cell biology, physiology, genome-editing technologies and assay development guiding our partners with long term robust translational strategies.
PREMIUM CRO SERVICES
DIABETES PRE-CLINICAL & CELL CULTURE SERVICES

Dr. Thomas Frogne
NOVO NORDISK
The EndoC-βH1 cell line is a valid model of human beta cells and applicable for screenings to identify novel drug target candidates.
MOLECULAR METABOLISM

Dr. Norbert Tennagels
SANOFI
Acute and repeated treatment with 5-PAHSA or 9-PAHSA isomers does not improve glucose control in mice.
CELL METABOLISM

Dr. Pia Davidsson
ASTRAZENECA
Secretagogin is increased in plasma from type 2 diabetes patients and potentially reflects stress and islet dysfunction.
PLOS ONE

Dr. Axel Haup
ELI LILLY
LY3298176, a novel dual GIP and GLP-1 receptor agonist for the treatment of type 2 diabetes mellitus: From discovery to clinical proof of concept.
MOLECULAR METABOLISM
TRULY TRANSLATIONAL HUMAN CELL MODELS
A PANEL OF UNIQUE PRODUCTS TO GET MEDICATION TO PATIENTS FASTER
VALIDATED BY OVER
INTERNATIONAL INSTITUTIONS
Accelerate and secure your Drug Discovery program using unique standardized disease models and assays
ROBUST
SCALABLE
DISEASE RELEVANT
PHYSIOLOGICAL
SENSITIVE
DATA REPRODUCIBILITY
A PATENTED CELL MATURATION PLATFORM
SCALABLE PRODUCTION OF FUNCTIONAL HUMAN CELL MODELS

To address industrial limitations in human cell model availability, Human Cell Design developed NatLine®, a patented platform that combines human iPSC or primary progenitor cells with advanced maturation technology.
NatLine® enables the large-scale, reproducible production of terminally differentiated cells that closely mimic native adult human cells — whether healthy or disease-specific — delivering translationally relevant models for R&D programs.
LATEST NEWS
American Diabetes Association’s 85th Scientific Sessions
American Diabetes Association’s 85th Scientific Sessions: Human Cell Design presents its latest research on glucolipotoxicity Scientists from Human Cell Design participated in the American Diabetes ...
Read moreImmunology Diabetes Study 2024 Conference Poster
20th Annual Congress of the Immunology Diabetes Study congress (IDS 2024): Discover the Human Cell Design poster. Human Cell Design has participated in the 20th IDS congress in Bruges (Belgium). During the ...
Read moreHuman Cell Design in China
Human Cell Design was present in China to meet you and discover your projects. Our expert was in China during 8 days with our exclusive distributor Lab Direct. We were delighted to meet our Chinese customers ...
Read more